Enzolytics Meets With Major Retailers at Recent ECRM Event
Industry: Health & Fitness
Company Wants to Roll Out IPF Immune™ to American Consumers
Boca Raton, FL (PRUnderground) October 7th, 2022
Enzolytics, Inc. promoted its IPF Immune™, a dietary supplement that supports the immune system, to dozens of retail buyers at the recent ECRM’s “Vitamin, Weight Management, and Sports Nutrition Program.”
“We had a great opportunity to pitch IPF Immune™ to some of the most sought-after retailers in the country,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas-based biotech company “We are reviewing the responses the buyers had and plan to follow up with them.
“We will be sending them samples and any additional information they need to make a a positive decision on carrying IPF Immune™,” Mr. Cotropia said. “We are working hard to add retail outlets in the coming months.”
ECRM brings buyers and brands with new products together for private meetings. Buyers attending the ECRM event represent regional and national food, drug, and mass chains.
Mr. Cotropia said retailers should want a product like IPF Immune™ because interest in immune boosters skyrocketed during the pandemic.
“Everyone is more focused on their health now,” he added. “They want to keep themselves healthy rather than wait until they are ill.”
IPF Immune™ is a dietary supplement that supports the body’s immune system by promoting normal immune function. It is a gluten-free dietary supplement that is taken orally two consecutive days per week for eight consecutive weeks.
“IPF Immune™ is a dietary supplement for the post-pandemic era,” Mr. Cotropia said. “Retailers know what consumers want and we believe our product is what they want.”
For more information, email firstname.lastname@example.org or visit enzolytics.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
About Enzolytics, Inc.
Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.